BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/21/2026 9:00:12 AM | Browse: 167 | Download: 347
Publication Name World Journal of Clinical Oncology
Manuscript ID 116601
Country China
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Nutrition & Dietetics
Manuscript Type Retrospective Cohort Study
Article Title Body mass index as a predictor of low muscle mass in patients with ESCC undergoing chemoradiotherapy
Manuscript Source Unsolicited Manuscript
All Author List Ling Xiao, Yu-Di Liu, Xue Zhang, Shi-Chuan Zhang and Jia-Hua Lyu
ORCID
Author(s) ORCID Number
Jia-Hua Lyu http://orcid.org/0000-0002-8560-1539
Funding Agency and Grant Number
Corresponding Author Jia-Hua Lyu, Associate Chief Physician, PhD, Senior Researcher, Department of Radiation Oncology, Sichuan Cancer Hospital, No. 55 Section 4, Renmin South Road, Chengdu 610041, Sichuan Province, China. winlttljh@163.com
Key Words Esophageal squamous cell carcinoma; Body mass index; Low muscle mass; Prognosis; Chemoradiotherapy
Core Tip Baseline body mass index (BMI) is a strong, independent predictor of low muscle mass (LMM) in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy. Higher BMI is associated with a significantly lower risk of LMM and improved survival. The combination of low BMI and LMM serves as a simple and effective composite marker for identifying high-risk patients with the poorest prognosis, highlighting the need for early nutritional and functional interventions to improve clinical outcomes.
Publish Date 2026-04-21 09:00
Citation

Xiao L, Liu YD, Zhang X, Zhang SC, Lyu JH. Body mass index as a predictor of low muscle mass in patients with ESCC undergoing chemoradiotherapy. World J Clin Oncol 2026; 17(4): 116601

URL https://www.wjgnet.com/2218-4333/full/v17/i4/116601.htm
DOI https://dx.doi.org/10.5306/wjco.v17.i4.116601
Full Article (PDF) WJCO-17-116601-with-cover.pdf